Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:43 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2257–2280 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Sleep Apnea, Snoring
Interventions: Kai Strap; Device
Lead sponsor: Kai Medical, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Aphasia
Interventions: Active tDCS plus Speech-Language Therapy, Sham plus Speech-Language Therapy; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Leukoplakia, Oral, Benign Neoplasms
Interventions: sulindac, Placebo; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Acne Vulgaris
Interventions: ultrasound; Device
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2008
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Testosterone Transdermal System, Placebo patch; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 40 Years to 70 Years · Female only
Enrollment: 610 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Peer Review, Research
Interventions: Intravenous fentanyl citrate, Duragesic®, Mylan generic fentanyl; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 45 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Nicotine Dependence
Interventions: lorcaserin, nicotine patch, placebo lorcaserin; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cigarette Smoker
Interventions: nicotine polacrilex, nicotine transdermal system, nicotine inhaler; Drug
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Prematurity, Very Low Birth Weight
Interventions: Silver Alginate; Device
Lead sponsor: Baylor Research Institute; Other
Eligibility: Up to 72 Hours
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Perimenopausal Depression, Depression
Interventions: Raloxifene, Rimostil, Transdermal Estradiol, Placebo skin patch and placebo tablets; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 40 Years to 60 Years · Female only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Ankle Sprain
Interventions: FS-67 Patch, Placebo Patch; Drug · Other
Lead sponsor: Hisamitsu Pharmaceutical Co., Inc.; Industry
Eligibility: 13 Years to 17 Years
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 23
States / cities: Birmingham, Alabama • Tucson, Arizona • Hot Springs, Arkansas + 19 more

Conditions: Dental Caries
Interventions: Silver Diamine Fluoride 38%, Group 2 (Placebo); Device
Lead sponsor: Justine Kolker; Other
Eligibility: 21 Years to 64 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Oral Lesion
Interventions: Electrical impedance imaging using Non-Significant Risk device (EII probe); Device
Lead sponsor: Ryan J. Halter; Other
Eligibility: 18 Years and older
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: SCC - Squamous Cell Carcinoma, Radiotracer, Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma
Interventions: Cetuximab (EGFR inhibitor), 18F-NOTA-ABY-030, Positron Emission Tomography (PET); Drug · Procedure
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Knee Injury
Interventions: Placement of allograft CR Plug in primary injury site; Procedure
Lead sponsor: RTI Surgical; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 3
States / cities: Los Angeles, California • Denver, Colorado • Indianapolis, Indiana

Conditions: Lichen Sclerosus, Lichen Sclerosus et Atrophicus
Interventions: Photography; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Relapse Remitting Multiple Sclerosis
Interventions: VAY736, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 2
States / cities: Long Beach, California • San Diego, California

Conditions: General Menstrual Discomfort
Interventions: Jovi Patch, Sham Patch; Device
Lead sponsor: Signal Relief; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Meadowbrook, Pennsylvania

Conditions: Human Immunodeficiency Virus, Human Papilloma Virus
Interventions: Oral HPV Sample; Diagnostic Test
Lead sponsor: Vivent Health; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Denver, Colorado • St Louis, Missouri • Milwaukee, Wisconsin

Conditions: Obstructive Sleep Apnea
Interventions: Obstructive Sleep Apnea Screening Device; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 100 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Acne Vulgaris
Interventions: BenzaClin, Effaclar; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Smoking, Nicotine Addiction, Surgery
Interventions: ENDD (NJOY), NRT (NicoDerm CQ), telephone counseling, brief advice, brochure; Behavioral · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Breast Cancer
Interventions: Microwave Ablation/ Coagulation Arm; Device
Lead sponsor: St. Joseph Hospital of Orange; Other
Eligibility: 18 Years to 90 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Orange, California

Conditions: Peripheral Arterial Disease, Critical Limb Ischemia
Interventions: Retrograde tibiopedal arterial access; Device
Lead sponsor: Cook Group Incorporated; Industry
Eligibility: Not listed
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 8
States / cities: Tucson, Arizona • Washington D.C., District of Columbia • Jacksonville, Florida + 5 more

Search by objective public record fields.

Study to Determine Results of Vibratory Stimulus on Subject's Neck

Effects of Transcranial Direct Current Stimulation in Post-stroke Aphasia

A Randomized Study of Sulindac in Oral Premalignant Lesions

A Study to Determine the Safety and Efficacy of an Ultrasound Device in the Management of Acute Acne Lesions

Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Fentanyl Patch Pharmacokinetics in Healthy Adults

Combination Nicotine Patch / Lorcaserin for Smoking Cessation

Validation of Biomarkers of Exposure and Host Response

The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants

Raloxifene and Rimostil for Perimenopause-Related Depression

FS-67 in the Treatment of Pediatric Patients With Ankle Sprain

Silver Diamine Fluoride Pilot Study (SDF)

Characterizing In Vivo Oral Lesion Impedances

Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

Evaluation of the CR Plug (Allograft) for the Treatment of a Cartilage Injury in the Knee.

Vulvar Scarring Grading Scale for Lichen Sclerosus

A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis

A Study of the Jovi Patch, Powered by Signal Relief, for the Improvement of General Menstrual Discomfort

The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV

Validation of Sleep Apnea Screening Device Phase II

Comparing OTC Acne Treatment to Prescription Regimen

The END Perioperative Smoking Pilot Study

Microwave Ablation of Breast Tumors

Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions